Close

Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'

Go back to Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'

Keryx Biopharma (KERX) Pulls-Back After Ripping Over 160% on Zerenex DAta

February 1, 2013 11:54 AM EST

Looks like the ride for Keryx Biopharmaceuticals Inc. (KERX) might be coming to a close.

After moving up 165 percent this week through Thursday, shares of Keryx are retracing a bit today. The stock is down over 15 percent on volume as traders look to cash out on some... More

Keryx Biopharma (KERX) Prices 8.23M Offering at $8.49/Share

January 31, 2013 6:53 AM EST

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share. In connection with this offering, Keryx granted to the underwriters a 30-day option to purchase 1,235,100 additional shares of... More